Bonesupport Holding AB (publ) (BOEUF)
USD 32.55
(-2.11%)
USD 32.55
(-2.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 591.07 Million SEK | 79.76% |
| 2022 | 328.81 Million SEK | 54.46% |
| 2021 | 212.88 Million SEK | 17.71% |
| 2020 | 180.86 Million SEK | 16.34% |
| 2019 | 155.46 Million SEK | 60.9% |
| 2018 | 96.62 Million SEK | -25.27% |
| 2017 | 129.3 Million SEK | 23.62% |
| 2016 | 104.59 Million SEK | 69.38% |
| 2015 | 61.75 Million SEK | 50.77% |
| 2014 | 40.96 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 184.41 Million SEK | 6.76% |
| 2024 Q3 | 237.5 Million SEK | 8.06% |
| 2024 Q2 | 219.79 Million SEK | 19.18% |
| 2023 Q4 | 172.74 Million SEK | 9.19% |
| 2023 Q2 | 140.38 Million SEK | 17.24% |
| 2023 Q1 | 119.74 Million SEK | 16.01% |
| 2023 Q3 | 158.2 Million SEK | 12.69% |
| 2023 FY | 591.07 Million SEK | 79.76% |
| 2022 FY | 328.81 Million SEK | 54.46% |
| 2022 Q1 | 66.34 Million SEK | 8.05% |
| 2022 Q2 | 74.63 Million SEK | 12.5% |
| 2022 Q4 | 103.22 Million SEK | 21.98% |
| 2022 Q3 | 84.62 Million SEK | 13.39% |
| 2021 Q1 | 44.82 Million SEK | -15.7% |
| 2021 Q4 | 61.4 Million SEK | 11.89% |
| 2021 Q3 | 54.87 Million SEK | 5.99% |
| 2021 Q2 | 51.77 Million SEK | 15.5% |
| 2021 FY | 212.88 Million SEK | 17.71% |
| 2020 Q3 | 48.07 Million SEK | 32.9% |
| 2020 Q4 | 53.17 Million SEK | 10.6% |
| 2020 Q1 | 43.43 Million SEK | -5.99% |
| 2020 Q2 | 36.17 Million SEK | -16.71% |
| 2020 FY | 180.86 Million SEK | 16.34% |
| 2019 Q2 | 37.32 Million SEK | 13.68% |
| 2019 Q4 | 46.19 Million SEK | 18.11% |
| 2019 Q1 | 32.82 Million SEK | 42.06% |
| 2019 FY | 155.46 Million SEK | 60.9% |
| 2019 Q3 | 39.11 Million SEK | 4.81% |
| 2018 Q3 | 14.24 Million SEK | -49.45% |
| 2018 Q1 | 31.08 Million SEK | 14.96% |
| 2018 FY | 96.62 Million SEK | -25.27% |
| 2018 Q4 | 23.1 Million SEK | 62.21% |
| 2018 Q2 | 28.18 Million SEK | -9.33% |
| 2017 Q1 | 32.45 Million SEK | 9.52% |
| 2017 FY | 129.3 Million SEK | 23.62% |
| 2017 Q4 | 27.03 Million SEK | -17.25% |
| 2017 Q3 | 32.67 Million SEK | -12.0% |
| 2017 Q2 | 37.13 Million SEK | 14.41% |
| 2016 Q4 | 29.63 Million SEK | 11.62% |
| 2016 Q2 | 25.16 Million SEK | 8.25% |
| 2016 Q1 | 23.25 Million SEK | 0.0% |
| 2016 FY | 104.59 Million SEK | 69.38% |
| 2016 Q3 | 26.54 Million SEK | 5.48% |
| 2015 FY | 61.75 Million SEK | 50.77% |
| 2014 FY | 40.96 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -18420.502% |
| Ansell Limited | 1.61 Billion USD | 63.498% |
| Ansell Limited | 1.61 Billion USD | 63.498% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -220.111% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -437556.51% |
| Psykey, Inc. | 419.29 Thousand USD | -140867.901% |
| ConvaTec Group Plc | 2.19 Billion USD | 73.06% |
| ConvaTec Group Plc | 2.14 Billion USD | 72.411% |
| Encision Inc. | 6.58 Million USD | -8874.91% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -32289.112% |
| LifePoint, Inc. | -18.5 Thousand USD | 3195110.811% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -8575.723% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -76464.378% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -59833.585% |
| Reflect Scientific, Inc. | 1.08 Million USD | -54621.549% |
| SmileDirectClub, Inc. | 470.74 Million USD | -25.563% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 68.419% |
| SheerVision, Inc. | 3.49 Million USD | -16790.776% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -42537.204% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -79229.292% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -566700.917% |